Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
All relapsing multiple sclerosis patients should be managed at a specialist clinic - YES.
The Indirect Costs of Multiple Sclerosis Associated With Absenteeism In Poland.
Pharmacoeconomic Aspects of Multiple Sclerosis Treatments in Iran.
A Real-World Assessment of Annual Multiple Sclerosis Prevalence and Disease-Modifying Drug Treatment Rates Using an Administrative Claims Database.
Papers: 8 May 2015 - 15 May 2015
Best Practices and Key Challenges in Cost-Effectiveness Modelling of Multiple Sclerosis Therapies.
Papers: 14 Aug 2015 - 21 Aug 2015
Papers: 22 May 2015 - 29 May 2015
Papers: 10 Oct 2015 - 17 Oct 2015
Quality of Life Among Patients with Multiple Sclerosis Treated with Prolonged-Release Fampridine 10 Mg Tablets for Walking Impairment.
European Multiple Sclerosis Platform 2016 Spring Conference
Sunshine, Sea, and Season of Birth: MS Incidence in Wales.
Further Understanding of the Immunopathology of Multiple Sclerosis: Impact on Future Treatments.
Biotinidase deficiency mimicking neuromyelitis optica beginning at the age of 4: A treatable disease.
Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.
Information processing speed in multiple sclerosis: Past, present, and future.
Does Current Portuguese Financing Model for Multiple Sclerosis Covers for Estimated Needs?
Co-occurrence of multiple sclerosis and Parkinson disease.
Papers: 31 Jul 2014 - 7 Aug 2014
Improving Clinical Outcomes and Health Care Resources Utilization in Multiple Sclerosis: A Portuguese Hospital Perspective.
Quantitative Susceptibility Mapping Indicates a Disturbed Brain Iron Homeostasis in Neuromyelitis Optica - A Pilot Study.
The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.
Papers: 22 Dec 2015 - 29 Dec 2015
Papers: 11 Sep 2015 - 18 Sep 2015
Papers: 17 Jul 2015 - 24 Jul 2015
Pages
« first
‹ previous
…
29
30
31
32
33
34
35
36
37
…
next ›
last »
